Phase 1 INTERCEPT-AD data published in Journal of Prevention of Alzheimer’s Disease supports continued development of sabirnetug (ACU193) for treatment of early Alzheimer’s disease (AD) ...

Neurodegenerative diseases pose a serious threat to public health, with an increasing impact among the elderly population.

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Studies have long warned that blows to the head may raise the risk of neurodegenerative conditions. Now, scientists believe ...

Researchers from Oxford's Institute of Population Ageing and the University of Manchester, and Tufts University have found that head injuries, such as ...

When brain tissues were exposed to repeated mild blows the dormant herpes simplex virus type 1 (HSV-1) became active. This ...

For decades, scientists have been trying to develop therapeutics for people living with Alzheimer’s disease, a progressive ...

Repeated head injuries, such as concussions - a known risk factor for Alzheimer’s disease (AD) - may reactivate a common ...

Researchers from Oxford’s Institute of Population Ageing and the University of Manchester, and Tufts University have found ...

Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...